Anales de Hematología
Número 105, 15 de Dic. de 2010
Contenido adicional
Noticias
- TROMBOEMBOLISMO PULMONAR: -Tromboembolismo pulmonar no sospechado en el Servicio de Urgencias
Resumen: Antecedentes y objetivos El tromboembolismo pulmonar (TEP) es una enfermedad que en ocasiones, se diagnostica con un elevado retraso, lo que puede provocar una mayor morbimortalidad. ...
- ACUTE LYMPHOBLASTIC LEUKEMIA: -Attacking remaining challenges in childhood leukemia
Approximately 80% of children with acute lymphoblastic leukemia (ALL) are now cured, with estimates that contemporary treatment may further increase the cure rate to near 90%.1 Yet this figure ...
- NEWS DRUGS & EFFECTS ANTI-LEUKEMIC: -Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
(WASHINGTON, April 9, 2012) –A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to ...
- AGRANULOCITOSIS POR CLOZAPINA: -Clozapina y agranulocitosis en España: ¿tenemos una población más segura? Seguimiento hematológico a 5 años de una cohorte de pacientes tratados con clozapina
Resumen y Introducción La clozapina es un fármaco de probada efectividad, sin embargo, su uso se asoció a la aparición de agranulocitosis y así, fue ...
- MINIMOLECULE GOVERNS SEVERITY OF ACUTE GRAFT-VS-HOST DISEASE: -Mini-molecule governs severity of acute graft-vs-host disease, study finds
Posted: 3/11/2012 Page Body Graft-versus-host disease is a life-threatening problem for many bone-marrow transplant recipients. New therapies are urgently needed to control the ...
- MYELOFIBROSIS: -A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
Myelofibrosis, a myeloproliferative neoplasm, is manifested by abnormal blood counts (anemia, thrombocytosis or thrombocytopenia, and leukocytosis or leukopenia), splenomegaly, and debilitating ...
- HEMATO-ONCOLOGY (JANUS KINASA 2)-JAK-2 INHIBITOR THERAPY FOR MYELOPROLIFERATIVE NEOPLASM: -Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms
William Vainchenker discovered the gain-of-function mutation in the gene encoding Janus kinase (JAK) 2 (JAK2 V617F) in early 2004 (reported in 2005)1 and subsequently described its association with ...
- HEMATO-ONCOLOGY: -Paraneoplastic thrombocytosis in ovarian cancer
Platelets are highly reactive cellular effectors of hemostasis, immunity, and inflammation.1 The concept that platelets play key roles in cancer growth and metastasis is long-standing. ...
- DERMATOLOGÍA: -Tratamiento del linfoma cutáneo de células B tipo folicular con rituximab intralesional
INTRODUCCIÓN Los linfomas cutáneos de células B (LCCB) son un grupo heterogéneo de procesos linfoproliferativos que se definen como afectación exclusiva ...
- HEMOPHILIA B: -Merry christmas for patients with hemophilia B
Hemophilia B (also known as Christmas disease) is due to deficiency of coagulation factor IX (FIX). In this issue of the Journal, Nathwani et al. report the first unequivocal evidence of ...
- HEMOFILIA B: -Adenovirus-associated virus vector–mediated gene transfer in hemophilia B
Hemophilia B is an X-linked bleeding disorder that results from a defect in the gene encoding coagulation factor IX (FIX), a serine protease that is critical for blood clotting. Persons with ...
- HEMATOLOGÍA: -Crean terapia exitosa para hemofilia
Una sola inyección podría ser suficiente para que los pacientes con hemofilia B, una forma del trastorno de coagulación sanguínea, no necesiten volver a tomar ...
- MULTIPLE MYELOMA: -Mayo Clinic: How patients will respond to immunomodulator therapy for multiple myeloma
SAN DIEGO -- Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior ...
- REMISSSION OF CHRONIC LYMPHOCITIC LEUKEMIA: -BETA CELL RECEPTOR INHIBITOR: -B cell receptor inhibitor causes chronic lymphocytic leukemia remission
PCI-32765 applies molecularly aimed attack to disease usually treated with chemotherapy combinations SAN DIEGO - A new, targeted approach to treating chronic lymphocytic leukemia has produced ...
- HEMATO-ONCOLOGY: -UH Seidman Cancer Center researchers present at American Society of Hematology Annual Meeting
New research findings in 25 presentations CLEVELAND: Researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine ...
